SBI Healthcare Opportunities Fund vs HDFC Pharma and Healthcare Fund

Portfolio Overlap Analysis · HDFC vs SBI

54.8%
High Overlap
16 common stocks · Rank #765 of 28,292 pairs
Fund A
SBI Healthcare Opportunities Fund
SBI · Sectoral - Pharma
Fund B
HDFC Pharma and Healthcare Fund
HDFC · Sectoral - Pharma

Common Holdings (10)

StockWt% in SBI Healthcare OpportunitiesWt% in HDFC Pharma and HealthcareOverlap
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
10.65%9.81%9.81%
Divi's Laboratories Ltd.
Pharmaceuticals & Biotechnology
7.55%8.38%7.55%
Max Healthcare Institute Ltd.
Healthcare Services
4.82%6.36%4.82%
Lupin Ltd.
Pharmaceuticals & Biotechnology
4.23%6.44%4.23%
Aster DM Healthcare Ltd.
Healthcare Services
3.85%5.42%3.85%
Acutaas Chemicals Ltd.
Pharmaceuticals & Biotechnology
4.77%3.60%3.60%
Fortis Healthcare Ltd.
Healthcare Services
3.24%4.02%3.24%
Krishna Institute of Medical Sciences Ltd.
Healthcare Services
2.92%3.61%2.92%
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
3.48%2.91%2.91%
Alkem Laboratories Ltd.
Pharmaceuticals & Biotechnology
2.77%6.21%2.77%

Unique to SBI Healthcare Opportunities

  • Apollo Hospitals Enterprise Ltd.5.76%
  • Torrent Pharmaceuticals Ltd.4.25%
  • Biocon Ltd.3.59%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Ipca Laboratories Ltd.4.80%
  • Anthem Biosciences Limited4.46%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
39.4% (11)
Healthcare Services
15.4% (5)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for SBI Healthcare Opportunities

More comparisons for HDFC Pharma and Healthcare

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.